AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise. The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).
Learn more about the comment process
AMIA responses are arranged by Federal Agency and Congressional Committee.
The current commercial health information technology (IT) arena encompasses a number of competing firms that provide electronic health applications to hospitals, clinical practices, and other healthcare-related entities. Such applications collect, store, and analyze patient information. Some vendors incorporate contract language whereby purchasers of health IT systems, such as hospitals and […]
AMIA comments on the HHS NPRM to modify HIPPA Privacy, Security and Enforcement Rules under the Health Information Technology for Economic and Clinical Act (HITECH) published in the Federal Register on July 14, 2010. The discussion focuses mainly on protecting the PHI of consumers by the way of business associates […]
AMIA comments to DEA on E-Prescribing Controlled Substances which would revise the Comprehensive Drug Abuse Prevention and Control Act of 1970 (Controlled Substances Act, or CSA) and the related regulations to allow healthcare providers to write prescriptions for controlled substances electronically. These revisions would have to allow e-prescribing controlled substances […]
AMIA comments on the proposed establishment of the Certification Programs for health information technology (HIT). AMIA agrees with the distinction between “testing” and “certification,” and support the use of the International Organization for Standard (ISO) and the International Electrotechnical Commission (IEC) ISO/IEC Guides to structure how testing, certification, and accreditation […]
AMIA offers comments to ONC on Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology. AMIA finds absence of detail in the certification criteria and to include directions for testing will ensure that vendor systems integrate standards, specifications, and criteria in ways […]
AMIA comments on the proposed rule which implements the initial stage of incentive funding for meaningful use (MU) of certified EHR technology. AMIA strongly believes that three principles are essential to achieving meaningful use of certified EHR technology: 1) we must invest in people, as well as technology; 2) users […]
AMIA’s testimony to the HIT Policy Committee, Adoption/Certification Workgroup, discusses potential unintended consequences of health information technology (HIT) and HIT policy, as well as effective options for addressing them. AMIA and its task force offer several recommendations that involve unintended consequences and conjure questions from previous observations in identifying safety […]
AMIA NIWG submits statement to the Institute of Medicine (IOM) and the Robert Wood Johnson Foundation Initiative on the future of nursing. NIWG recognizes the importance of increasing the nursing workforce and to prepare them to meet the educational challenges of implementing HIT on a grand scale. They embrace several […]
AMIA comments on the interim final rule, which amends the enforcement regulations promulgated under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) to conform to the revisions made pursuant to the Health Information Technology for Economic and Clinical Health Act (HITECH) for which the Secretary may impose a […]
AMIA comments on the proposed rule to the Genetic Information Nondiscrimination Act of 2008 (GINA). AMIA supports the inclusion in the HIPAA Privacy Rule to prohibit against the use of genetic information for underwriting purposes. Covered entities (CE) would use genetic information only to benefit the individual and not for […]